A novel screening test for inappropriate shocks due to myopotentials from the subcutaneous implantable cardioverter–defibrillator

[1]  P. Lambiase,et al.  Understanding Outcomes with the S-ICD in Primary Prevention Patients with Low EF Study (UNTOUCHED): Clinical characteristics and perioperative results. , 2019, Heart rhythm.

[2]  D. Steven,et al.  Incidence of myopotential induction in subcutaneous implantable cardioverter-defibrillator patients: Is the oversensing issue really solved? , 2019, Heart rhythm.

[3]  S. Naito,et al.  Subcutaneous Implantable Cardioverter Defibrillator Lead Repositioning for Preventing Inappropriate Shocks Due to Myopotential Oversensing in a Post-Fulminant Myocarditis Patient. , 2019, International heart journal.

[4]  D. Corrado,et al.  Multicentre experience with the second‐generation subcutaneous implantable cardioverter defibrillator and the intermuscular two‐incision implantation technique , 2019, Journal of cardiovascular electrophysiology.

[5]  J. Roos‐Hesselink,et al.  Evaluation of a novel automatic screening tool for determining eligibility for a subcutaneous implantable cardioverter-defibrillator. , 2018, International journal of cardiology.

[6]  A. Auricchio,et al.  Prospective blinded evaluation of a novel sensing methodology designed to reduce inappropriate shocks by the subcutaneous implantable cardioverter-defibrillator. , 2018, Heart rhythm.

[7]  K. Wasmer,et al.  Direct comparison of the novel automated screening tool (AST) versus the manual screening tool (MST) in patients with already implanted subcutaneous ICD. , 2018, International journal of cardiology.

[8]  D. Theuns,et al.  Six‐year follow‐up of the initial Dutch subcutaneous implantable cardioverter‐defibrillator cohort: Long‐term complications, replacements, and battery longevity , 2018, Journal of cardiovascular electrophysiology.

[9]  M. Kimura,et al.  Safety and Efficacy of Subcutaneous Cardioverter Defibrillator in Patients at High Risk of Sudden Cardiac Death　- Primary Japanese Experience. , 2018, Circulation journal : official journal of the Japanese Circulation Society.

[10]  M. Biffi,et al.  Subcutaneous implantable cardioverter defibrillator eligibility according to a novel automated screening tool and agreement with the standard manual electrocardiographic morphology tool , 2018, Journal of Interventional Cardiac Electrophysiology.

[11]  J. DiNicolantonio,et al.  Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Meta-Analysis of Case-Control Studies. , 2017, JACC. Clinical electrophysiology.

[12]  Michael R Gold,et al.  Subcutaneous implantable cardioverter-defibrillator Post-Approval Study: Clinical characteristics and perioperative results. , 2017, Heart rhythm.

[13]  Pier D Lambiase,et al.  Implant and Midterm Outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator Registry: The EFFORTLESS Study. , 2017, Journal of the American College of Cardiology.

[14]  S. Iliceto,et al.  Intermuscular Two‐Incision Technique for Subcutaneous Implantable Cardioverter Defibrillator Implantation: Results from a Multicenter Registry , 2017, Pacing and clinical electrophysiology : PACE.

[15]  P. De Filippo,et al.  Intermuscular pocket for subcutaneous implantable cardioverter defibrillator: Single-center experience , 2016, Journal of arrhythmia.

[16]  Arthur A M Wilde,et al.  Inappropriate shocks in the subcutaneous ICD: Incidence, predictors and management. , 2015, International journal of cardiology.

[17]  Pier D. Lambiase,et al.  The learning curve associated with the introduction of the subcutaneous implantable defibrillator , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[18]  Pier D. Lambiase,et al.  Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator: 2-Year Results From a Pooled Analysis of the IDE Study and EFFORTLESS Registry. , 2015, Journal of the American College of Cardiology.

[19]  M. Gold,et al.  A New Algorithm to Reduce Inappropriate Therapy in the S‐ICD System , 2015, Journal of cardiovascular electrophysiology.

[20]  M. Gold,et al.  Use of a discrimination algorithm to reduce inappropriate shocks with a subcutaneous implantable cardioverter-defibrillator. , 2014, Heart rhythm.

[21]  Mark Kremers,et al.  Safety and Efficacy of a Totally Subcutaneous Implantable-Cardioverter Defibrillator , 2013, Circulation.

[22]  A. Wilde,et al.  Two-incision technique for implantation of the subcutaneous implantable cardioverter-defibrillator. , 2013, Heart rhythm.

[23]  M. Shoda,et al.  Guidelines for Non-Pharmacotherapy of Cardiac Arrhythmias (JCS 2011). , 2012, Circulation journal : official journal of the Japanese Circulation Society.

[24]  Alexander H Maass,et al.  An entirely subcutaneous implantable cardioverter-defibrillator. , 2010, The New England journal of medicine.

[25]  M. Haïssaguerre,et al.  Oversensing issues leading to device extraction: when subcutaneous implantable cardioverter defibrillator reached a dead-end. , 2019, Heart rhythm.